Meeting Coverage:

Glaucoma 360 New Horizons Forum

Glaucoma 360: 2018

New Horizons in Pharmaceuticals

Show Description +

Lama A. Al-Aswad, MD, MPH, shares why she feels this is an exciting time for pharmaceuticals. Dr. Al-Aswad comments on how previously no new class of glaucoma drugs had been approved since the 1990s but now two recently approved medications are changing the space.

Posted: 1/17/2018

Up Next

Applying VR to Glaucoma

Felipe A. Medeiros, MD, PhD


The Glaucoma Renaissance

Kuldev Singh, MD, MPH

Interventional Glaucoma: A New Mindset

Iqbal Ike K. Ahmed, MD, FRCSC

Developments in Drug Delivery

Anne L. Coleman, MD, PhD, James D. Brandt, MD

New Horizons in Pharmaceuticals

Lama A. Al-Aswad, MD, MPH, shares why she feels this is an exciting time for pharmaceuticals. Dr. Al-Aswad comments on how previously no new class of glaucoma drugs had been approved since the 1990s but now two recently approved medications are changing the space.

Posted: 1/17/2018


Please log in to leave a comment.

More From Glaucoma 360: 2018 Coverage

Interventional Glaucoma: A New Mindset

Iqbal Ike K. Ahmed, MD, FRCSC

Developments in Drug Delivery

Anne L. Coleman, MD, PhD, James D. Brandt, MD

Applying VR to Glaucoma

Felipe A. Medeiros, MD, PhD